Massive study of 7,000 preemies aims to save sight
NCT ID NCT07312669
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at over 7,000 premature infants to understand which babies develop a serious eye condition called retinopathy of prematurity (ROP) and need treatment. Researchers used a cloud-based database to compare risk factors and outcomes. The goal was to improve guidelines that protect vision in these vulnerable newborns.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could lead to better screening guidelines that help prevent blindness in premature infants.
- What could go wrong
- This is an observational study, not a treatment trial, so it cannot directly prove what works best. Results may not apply to all hospitals or regions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINOPATHY OF PREMATURITY (ROP) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Alaska Children's EYE & Strabismus
Anchorage, Alaska, 99508, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new window into Babies' eyes: can advanced imaging improve care for premature infants?
- Can a gentle eye scan replace stressful exams for preterm infants?
- Can smarter screening save premature Babies' sight?
- Can a lower dose of an eye drug protect preterm Infants' sight?
- Can a single eye injection save sight in premature infants?
- Nasal fentanyl spray could ease painful eye exams for premature babies